InvestorsHub Logo
Followers 7
Posts 5499
Boards Moderated 0
Alias Born 09/11/2013

Re: None

Wednesday, 08/31/2016 4:50:49 PM

Wednesday, August 31, 2016 4:50:49 PM

Post# of 146201
I found some good starting points for research at this link:

http://seekingalpha.com/article/3980143-driving-nanoviricides-extreme-moves-second-half-expectations

Here is an excerpt and I've included commentary of my own in brackets.

Summary

NNVC has inked arrangements with 3 prestigious university laboratories to help select anti-Herpes drug candidates. [this was early in the year and still no materials have been sent for testing. It makes the inked arrangements quite irrelevant as agreements such as these can be drawn up by just about anybody at any time as long as you've got the money to pay for it. who really cares if agreements were signed if they are never utilized?]

NNVC has also signed an agreement with St. Jude's medical center to complete pre-clinical testing for its anti-influenza drug candidate. [ditto to my comment above]

NNVC remains in a stable financial condition with sufficient resources to move its lead drug candidates forward. [and to provide lifestyle salaries, bonuses and perks to Seymour and Diwan for years to come, regardless of product development]


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News